Consun Pharmaceutical Group Limited (HKG: 1681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
8.45
-0.03 (-0.35%)
Nov 21, 2024, 4:08 PM HKT

Consun Pharmaceutical Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
836.41784.53682.91590.17498.7979.82
Upgrade
Depreciation & Amortization
79.2878.0976.3672.9971.873.12
Upgrade
Loss (Gain) From Sale of Assets
0.850.854.121.990.240.33
Upgrade
Asset Writedown & Restructuring Costs
-----326.14
Upgrade
Loss (Gain) From Sale of Investments
-0.23-0.23----
Upgrade
Stock-Based Compensation
---1.7823.4112.1719.92
Upgrade
Provision & Write-off of Bad Debts
-12.6-12.6-32.49-18.0429.3670.35
Upgrade
Other Operating Activities
41.3-239.93-90.34-52.41-66.59
Upgrade
Change in Accounts Receivable
-1.71-1.71113.87114.21304.4625.6
Upgrade
Change in Inventory
-102.02-102.02-54.9-39.56-28.5-4.03
Upgrade
Change in Accounts Payable
80.7680.76114.4150.9941.43-139.67
Upgrade
Change in Unearned Revenue
-0.46-0.462.261.67-1.14-1.66
Upgrade
Change in Other Net Operating Assets
-6.24-6.24318.04-9.14-
Upgrade
Operating Cash Flow
915.34818.97947.68725.54867.06383.32
Upgrade
Operating Cash Flow Growth
5.34%-13.58%30.62%-16.32%126.20%-49.18%
Upgrade
Capital Expenditures
-82.71-52.56-51.59-98.25-48.7-179.75
Upgrade
Sale of Property, Plant & Equipment
0.480.151.20.320.111.04
Upgrade
Sale (Purchase) of Intangibles
-----5-0.18
Upgrade
Investment in Securities
-470.82-248.27-365.67-230--
Upgrade
Other Investing Activities
86.0368.9247.2629.6227.8916.75
Upgrade
Investing Cash Flow
-467.02-231.77-368.8-298.31-25.7-110.13
Upgrade
Long-Term Debt Issued
-442.39259.32295.72263.76607.46
Upgrade
Total Debt Issued
371.11442.39259.32295.72263.76607.46
Upgrade
Long-Term Debt Repaid
--382.93-436.67-235.81-237.92-459.97
Upgrade
Total Debt Repaid
-382.31-382.93-436.67-235.81-237.92-459.97
Upgrade
Net Debt Issued (Repaid)
-11.259.46-177.3559.9125.83147.49
Upgrade
Issuance of Common Stock
129.1314.22.6414.57-2.49
Upgrade
Repurchase of Common Stock
---29.07-30.15-152.75-46.21
Upgrade
Common Dividends Paid
-568.39-326.25-127.49-198.08-131.49-225.55
Upgrade
Other Financing Activities
-33.89-27.51-10.93-12.91-21.4-34.88
Upgrade
Financing Cash Flow
-484.34-280.1-342.21-166.66-279.8-156.66
Upgrade
Foreign Exchange Rate Adjustments
-12.26-9.0117.18-4.52-4.51-3.04
Upgrade
Net Cash Flow
-48.28298.09253.85256.05557.04113.49
Upgrade
Free Cash Flow
832.63766.41896.09627.29818.36203.57
Upgrade
Free Cash Flow Growth
0.55%-14.47%42.85%-23.35%302.00%-63.70%
Upgrade
Free Cash Flow Margin
30.40%29.59%38.30%30.68%46.69%11.78%
Upgrade
Free Cash Flow Per Share
1.030.961.130.781.000.24
Upgrade
Cash Interest Paid
7.471.090.5612.9121.424.72
Upgrade
Cash Income Tax Paid
25.1220.0313.21134.68115.32125.4
Upgrade
Levered Free Cash Flow
574.46507.99650.74464.15708.42199.5
Upgrade
Unlevered Free Cash Flow
591.61521.28657.57472.21721.8214.11
Upgrade
Change in Net Working Capital
-43.2220.45-187.46-61.45-347.719.23
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.